3. Collister JP, Hendel MD. Chronic effects of angiotensin II and AT1 27.
receptor antagonists in subfornical organ-lesioned rats. Clin Exp Pharmacol Physiol 32: 462– 466, 2005.
4. Cox BF, Bishop VS. Neural and humoral mechanisms of angiotensin- 28.
dependent hypertension. Am J Physiol Heart Circ Physiol 261: H1284 –
H1291, 1991.
5. Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH. 29.
In vivo evidence for antioxidant potential of estrogen in microvessels of
female spontaneously hypertensive rats. Hypertension 39: 405– 411, 2002.
6. Dean SA, Tan J, O'Brien ER, Leenen FH. 17 -Estradiol downregulates 30.
tissue angiotensin-converting enzyme and ANG II type 1 receptor in
female rats. Am J Physiol Regul Integr Comp Physiol 288: R759 –R766,
2005. 31.
7. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M.
Multiple actions of steroid hormones: a focus on rapid, nongenomic
effects. Pharmacol Rev 52: 513–556, 2000.
8. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ 32.
and area postrema: implications for long term control of autonomic output.
Clin Exp Pharmacol Physiol 24: 96 –101, 1997.
9. Ferguson AV, Wall KM. Central actions of angiotensin in cardiovascular 33.
control: multiple roles for a single peptide. Can J Physiol Pharmacol 70:
779 –785, 1992.
10. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 78:
583– 686, 1998. 34.
11. Florian M, Freiman A, Magder S. Treatment with 17-beta-estradiol
reduces superoxide production in aorta of ovariectomized rats. Steroids
69: 779 –787, 2004.
12. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus atten- 35.
uates L-glutamate-induced increases in mean arterial pressure through
estrogen receptor beta and NO. Hypertension 48: 1130 –1136, 2006.
13. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen
reduces angiotensin II-induced nitric oxide synthase and NADPH oxidase 36.
expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38 – 44,
2003.
14. Hendel MD, Collister JP. Contribution of the subfornical organ to 37.
angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol
288: H680 –H685, 2005. 38.
15. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of
estrogen replacement therapy on serum lipid values and angiographically
defined coronary artery disease in postmenopausal women. Am J Cardiol 39.
69: 176 –178, 1992.
16. Kisley LR, Sakai RR, Fluharty SJ. Estrogen decreases hypothalamic
angiotensin II AT1 receptor binding and mRNA in the female rat. Brain 40.
Res 844: 34 – 42, 1999.
17. Komesaroff PA, Black CV, Westerman RA. A novel, nongenomic
action of estrogen on the cardiovascular system. J Clin Endocrinol Metab
83: 2313–2316, 1998. 41.
18. Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in 42.
perimenopausal women. J Clin Endocrinol Metab 84: 606 – 610, 1999.
19. Komesaroff PA, Fullerton M, Dart AM, Jennings GL, Sudhir K. 43.
Estrogen supplementation improves vascular reactivity in hypogonadal
men. Proc 80th Meeting of the Endocrine Soc. P2– 640, 1998.
20. Ma FY, Grattan DR, Bobrovskaya L, Dunkley PR, Bunn SJ. Angio- 44.
tensin II regulates tyrosine hydroxylase activity and mRNA expression in
rat mediobasal hypothalamic cultures: the role of specific protein kinases.
J Neurochem 90: 431– 441, 2004. 45.
21. Laufs U, Adam O, Strehlow K, Wassmann S, Konkol C, Laufs K,
Schmidt W, Bohm M, Nickenig G. Down-regulation of Rac-1 GTPase
by estrogen. J Biol Chem 278: 5956 –5962, 2003. 46.
22. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588 –593, 1997.
23. Lu N, Helwig BG, Fels RJ, Parimi S, Kenney MJ. Central Tempol alters 47.
basal sympathetic nerve discharge and attenuates sympathetic excitation to
central ANG II. Am J Physiol Heart Circ Physiol 287: H2626 –H2633,
2004.
24. Mendelsohn ME, Kara RH. Molecular and cellular basis of cardiovas- 48.
cular gender differences. Science 308: 1583–1587, 2005.
25. Mendelsohn ME. Protective effects of estrogen on the cardiovascular
system. Am J Cardiol 89: 12E–18E, 2002. 49.
Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni
U, Russo A. Biologically active metal-independent superoxide dismutase
mimics. Biochemistry 29: 2802–2807, 1990.
